S&P 500 slumps as jobs data stoke economic concerns offsetting Fed rate cut bets
LONDON - Ananda Pharma plc (AQSE:ANA, OTC: ANANF) announced Monday that its senior leadership team will attend the Science in the City International conference on September 11-12, 2025, in Bordeaux, France.
The UK-based biopharmaceutical company, which develops cannabidiol medicines for chronic conditions, will be represented by Chairman Charles Morgan and CEO Melissa Sturgess. Sturgess will deliver a keynote speech at the pre-conference reception on September 11, focusing on the need for regulatory approved CBD therapeutics for endometriosis treatment. Company representative Megan Morris will attend the New York simulcast event.
Science in the City International is described as an EU educational summit bringing together plant-based executives and healthcare leaders. The event will be held at La Cité Du Vin in Bordeaux and aims to connect industry stakeholders, medical professionals, and healthcare leaders around evidence-based emerging topics in plant-based healthcare.
Ananda Pharma specializes in developing regulatory approved cannabinoid medicines targeting conditions including endometriosis and chemotherapy-induced peripheral neuropathy. The company notes that endometriosis affects approximately 10% of women and currently lacks effective treatment options.
The announcement was made in a press release statement from the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.